Novo Nordisk 鞭笞Wegovy的价格下降了23%,使未投保的病人更容易获得减重药物。 Novo Nordisk slashes Wegovy price by 23%, making the weight-loss drug more accessible to uninsured patients.

丹麦药商Novo Nordisk将其体重损失药物Wegovy的价格降低23%, 达到每月499美元, Danish drugmaker Novo Nordisk has cut the price of its weight-loss drug Wegovy by 23%, to $499 per month, for uninsured patients and those with insurance not covering obesity treatments. 这是继Eli Lilly对Zepbound毒品同样降低价格之后的结果。 This follows a similar price reduction by Eli Lilly for its drug Zepbound. 两者都是GLP-1级的一部分,以抑制食欲和促进充分性而闻名。 Both are part of the GLP-1 class, known for curbing appetite and promoting fullness. 林业发展局已将这两种药物从短缺名单上删除,表明供应情况有所改善。 The FDA has removed both drugs from its shortage list, signaling improved supply.